Cargando…
The effectiveness and safety of recombinant human growth hormone combined with alginate dressing in the treatment of diabetic foot ulcer: A protocol for systematic review and meta-analysis
BACKGROUND: Diabetic foot ulcer (DFU) is one of the serious complications of diabetes. It is the result of a joint effect of lower extremities vascular lesions, neuropathy, and infection, which require amputation and even threaten the life of the patient. At present, the conventional treatment for D...
Autores principales: | Zhou, Deng-Rong, Deng, Hai-Yan, Pu, Lin-Li, Lin, Shao-Lan, Gou, Rong, Wang, Feng-Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7870157/ https://www.ncbi.nlm.nih.gov/pubmed/33592853 http://dx.doi.org/10.1097/MD.0000000000023984 |
Ejemplares similares
-
Exploring the pathogenesis of osteomyelitis accompanied by diabetic foot ulcers using microarray data analysis
por: Fan, Pan, et al.
Publicado: (2023) -
Adjacent Fu’s subcutaneous needling as an adjunctive healing strategy for diabetic foot ulcers: Two case reports
por: Qi, Fei, et al.
Publicado: (2022) -
Cardiovascular Autonomic Dysfunction Predicts Diabetic Foot Ulcers in Patients With Type 2 Diabetes Without Diabetic Polyneuropathy
por: Yun, Jae-Seung, et al.
Publicado: (2016) -
Efficacy and safety of the recombinant human growth hormone in short children born small for gestational age: A randomized, multicentre, comparative phase III trial
por: Kim, Su Jin, et al.
Publicado: (2021) -
Three-week topical treatment with placenta-derived mesenchymal stem cells hydrogel in a patient with diabetic foot ulcer: A case report
por: Zeng, Xiangxia, et al.
Publicado: (2017)